These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9865739)

  • 1. Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.
    Flad T; Spengler B; Kalbacher H; Brossart P; Baier D; Kaufmann R; Bold P; Metzger S; Blüggel M; Meyer HE; Kurz B; Müller CA
    Cancer Res; 1998 Dec; 58(24):5803-11. PubMed ID: 9865739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.
    Bernhard H; Jäger E; Maeurer MJ; Meyer zum Büschenfelde KH; Knuth A
    Tissue Antigens; 1996 Jul; 48(1):22-31. PubMed ID: 8864171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.
    Hofmann S; Glückmann M; Kausche S; Schmidt A; Corvey C; Lichtenfels R; Huber C; Albrecht C; Karas M; Herr W
    Mol Cell Proteomics; 2005 Dec; 4(12):1888-97. PubMed ID: 16112985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.
    Dörrschuck A; Schmidt A; Schnürer E; Glückmann M; Albrecht C; Wölfel C; Lennerz V; Lifke A; Di Natale C; Ranieri E; Gesualdo L; Huber C; Karas M; Wölfel T; Herr W
    Blood; 2004 Oct; 104(8):2591-9. PubMed ID: 15231579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
    Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma.
    Sato E; Torigoe T; Hirohashi Y; Kitamura H; Tanaka T; Honma I; Asanuma H; Harada K; Takasu H; Masumori N; Ito N; Hasegawa T; Tsukamoto T; Sato N
    Clin Cancer Res; 2008 Nov; 14(21):6916-23. PubMed ID: 18980986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes.
    Ge HL; Wang Y; Wang SJ; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2006 Feb; 38(2):110-8. PubMed ID: 16474902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
    Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.
    Schendel DJ; Gansbacher B; Oberneder R; Kriegmair M; Hofstetter A; Riethmüller G; Segurado OG
    J Immunol; 1993 Oct; 151(8):4209-20. PubMed ID: 8409397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HLA class I-restricted tumor-associated antigens in adult T cell leukemia cells by mass spectrometric analysis.
    Kawahara M; Hori T; Matsubara Y; Okawa K; Uchiyama T
    Exp Hematol; 2006 Nov; 34(11):1496-504. PubMed ID: 17046569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.
    Bernhard H; Maeurer MJ; Jäger E; Wölfel T; Schneider J; Karbach J; Seliger B; Huber C; Storkus WS; Lotze MT; Meyer zum Büschenfelde KH; Knuth A
    Scand J Immunol; 1996 Sep; 44(3):285-92. PubMed ID: 8795723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.
    Gloger A; Ritz D; Fugmann T; Neri D
    Cancer Immunol Immunother; 2016 Nov; 65(11):1377-1393. PubMed ID: 27600516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells.
    Seliger B; Dressler SP; Massa C; Recktenwald CV; Altenberend F; Bukur J; Marincola FM; Wang E; Stevanovic S; Lichtenfels R
    Proteomics; 2011 Jun; 11(12):2528-41. PubMed ID: 21595034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry.
    Woods AS; Huang AY; Cotter RJ; Pasternack GR; Pardoll DM; Jaffee EM
    Anal Biochem; 1995 Mar; 226(1):15-25. PubMed ID: 7785766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
    Yamaguchi H; Tanaka F; Ohta M; Inoue H; Mori M
    Clin Cancer Res; 2004 Feb; 10(3):890-6. PubMed ID: 14871964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
    Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
    Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinaselike 5 is a novel target of immunotherapy in adult T-cell leukemia.
    Kawahara M; Hori T; Matsubara Y; Okawa K; Uchiyama T
    J Immunother; 2007; 30(5):499-505. PubMed ID: 17589290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene.
    Hogan KT; Eisinger DP; Cupp SB; Lekstrom KJ; Deacon DD; Shabanowitz J; Hunt DF; Engelhard VH; Slingluff CL; Ross MM
    Cancer Res; 1998 Nov; 58(22):5144-50. PubMed ID: 9823325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
    Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
    Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.
    Schag K; Schmidt SM; Müller MR; Weinschenk T; Appel S; Weck MM; Grünebach F; Stevanovic S; Rammensee HG; Brossart P
    Clin Cancer Res; 2004 Jun; 10(11):3658-66. PubMed ID: 15173072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.